Trial record 1 of 1 for:
NeuroSystec
Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus
This study has been terminated.
Sponsor:
NeuroSystec Corporation
Information provided by (Responsible Party):
NeuroSystec Corporation
ClinicalTrials.gov Identifier:
NCT00957788
First received: August 10, 2009
Last updated: April 18, 2013
Last verified: June 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | May 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |